Relmada Therapeutics Inc logo

Relmada Therapeutics Inc

STU:4E2 (USA)  
€ 2.76 (-0.72%) Jun 18
At Loss
P/B:
1.27
Market Cap:
€ 85.13M ($ 91.52M)
Enterprise V:
€ 7.28M ($ 7.82M)
Volume:
-
Avg Vol (2M):
-
Trade In:

Relmada Therapeutics Inc Valuation Measures